Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2
- PMID: 34205861
- PMCID: PMC8228758
- DOI: 10.3390/vaccines9060572
Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2
Abstract
Seven immunocompetent patients aged > 50 years old presented with herpes zoster (HZ) infection in a median of 9 days (range 7-20) after vaccination against SARS-CoV-2. The occurrence of HZ within the time window 1-21 days after vaccination defined for increased risk and the reported T cell-mediated immunity involvement suggest that COVID-19 vaccination is a probable cause of HZ. These cases support the importance of continuing assessment of vaccine safety during the ongoing massive vaccination for the COVID-19 pandemic and encourage reporting and communication of any vaccination-associated adverse event.
Keywords: SARS-CoV-2; herpes zoster; mRNA vaccines.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Garcia-Montero C., Fraile-Martinez O., Bravo C., Torres-Garranza D., Sanchez-Trujillo L., Gomez-Lahoz A.M., Guijarro L.G., Garcia-Honduvilla N., Asunsolo A., Bujan J., et al. An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic times. Vaccines. 2021;9:433. doi: 10.3390/vaccines9050433. - DOI - PMC - PubMed
-
- WHO Coronavirus (COVID-19) Dashboard Geneva: World Health Organization. 5 April 2021. [(accessed on 29 May 2021)]; Available online: https://covid19.who.int/
LinkOut - more resources
Full Text Sources
Miscellaneous